These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 6783287)
41. Polyvalent antisera to Pseudomonas ribosomal vaccines: protection of mice against clinically isolated strains. Lieberman MM; Wright GL; Wolcott KM; McKissock-Desoto DC Infect Immun; 1980 Aug; 29(2):489-93. PubMed ID: 6783532 [TBL] [Abstract][Full Text] [Related]
42. [Evaluation of the specific activity of hyperimmune anti-Pseudomonas aeruginosa human plasma in an experiment]. Podgornaia LG; Shinkarenko AA; Krokhina MA; Dziuban NF; D'iachenko VF Patol Fiziol Eksp Ter; 1987; (2):70-2. PubMed ID: 3112715 [No Abstract] [Full Text] [Related]
43. Protection against Pseudomonas aeruginosa infection by immunisation with fractions of culture filtrates of Ps. aeruginosa. Jones RJ Br J Exp Pathol; 1968 Oct; 49(5):411-20. PubMed ID: 4973304 [No Abstract] [Full Text] [Related]
44. Obtention and assay of rabbit anti-Pseudomonas serum. Laborde HF; Legnani de Fajardo C J Bacteriol; 1969 Jun; 98(3):992-5. PubMed ID: 4182531 [TBL] [Abstract][Full Text] [Related]
46. [Polish preparations for preventing and treating infections caused by Pseudomonas aeruginosa]. Schiller B; Buchowicz I; Lysakowska E; Sakiel S; Korbecki M Zh Mikrobiol Epidemiol Immunobiol; 1985 Apr; (4):30-2. PubMed ID: 2409720 [TBL] [Abstract][Full Text] [Related]
47. Immunization with R mutants of S. Minnesota. I. Protection against challenge with heterologous gram-negative bacilli. McCabe WR J Immunol; 1972 Mar; 108(3):601-10. PubMed ID: 4622185 [No Abstract] [Full Text] [Related]
48. [Cell-free pseudomonas vaccine. I. Enzyme properties and virulence of strains of P. aeruginosa; protective activity of their water-soluble antigens]. Stanislavskiĭ ES; Zhvanetskaia MI; Mashilova GM; Gladus MA Zh Mikrobiol Epidemiol Immunobiol; 1980 Aug; (8):66-72. PubMed ID: 6778035 [TBL] [Abstract][Full Text] [Related]
49. Immunization with Pseudomonas aeruginosa outer membrane vesicles stimulates protective immunity in mice. Zhang X; Yang F; Zou J; Wu W; Jing H; Gou Q; Li H; Gu J; Zou Q; Zhang J Vaccine; 2018 Feb; 36(8):1047-1054. PubMed ID: 29406241 [TBL] [Abstract][Full Text] [Related]
50. Synergistic effect of immune gamma-globulin fraction on protection by antibiotic against corneal ulcers in experimental mice infected with Pseudomonas aeruginosa. Kawaharajo K; Homma JY Jpn J Exp Med; 1976 Jun; 46(3):155-65. PubMed ID: 822190 [TBL] [Abstract][Full Text] [Related]
51. Intratracheal immunization with pili protein protects against mortality associated with Pseudomonas aeruginosa pneumonia in mice. Ohama M; Hiramatsu K; Miyajima Y; Kishi K; Nasu M; Kadota J FEMS Immunol Med Microbiol; 2006 Jun; 47(1):107-15. PubMed ID: 16706793 [TBL] [Abstract][Full Text] [Related]
52. Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal pseudomonas sepsis. Hemachandra S; Kamboj K; Copfer J; Pier G; Green LL; Schreiber JR Infect Immun; 2001 Apr; 69(4):2223-9. PubMed ID: 11254577 [TBL] [Abstract][Full Text] [Related]
53. Active and passive immunity against Pseudomonas aeruginosa with a ribosomal vaccine and antiserum in C3H/HeJ mice. Lieberman MM; Ayala E J Immunol; 1983 Jul; 131(1):1-3. PubMed ID: 6408166 [No Abstract] [Full Text] [Related]
54. Mechanisms of lipopolysaccharide-induced protection against pseudomonas sepsis in granulocytopenic mice. Tegtmeier BR; Andersen BR Rev Infect Dis; 1983; 5 Suppl 5():S963-70. PubMed ID: 6419318 [TBL] [Abstract][Full Text] [Related]
55. Protection against fatal Pseudomonas aeruginosa pneumonia in mice after nasal immunization with a live, attenuated aroA deletion mutant. Priebe GP; Meluleni GJ; Coleman FT; Goldberg JB; Pier GB Infect Immun; 2003 Mar; 71(3):1453-61. PubMed ID: 12595463 [TBL] [Abstract][Full Text] [Related]
56. [The protective activity of 2 normal immunoglobulin preparations for intravenous administration in experimental Pseudomonas aeruginosa infection]. Vasilev ChL; Veleva KV; Tekelieva RKh; Pencheva PI Zh Mikrobiol Epidemiol Immunobiol; 1991 Feb; (2):54-6. PubMed ID: 1907793 [TBL] [Abstract][Full Text] [Related]
57. Salmonella Typhimurium strain expressing OprF-OprI protects mice against fatal infection by Pseudomonas aeruginosa. Zhang M; Sun C; Gu J; Yan X; Wang B; Cui Z; Sun X; Tong C; Feng X; Lei L; Han W Microbiol Immunol; 2015 Sep; 59(9):533-44. PubMed ID: 26249788 [TBL] [Abstract][Full Text] [Related]